Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04629014 · ClinicalTrials.gov registry record
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
A clinical trial of Pediatric Intestinal Failure, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 750
- Enrollment target
- 14
- Study locations
NCT04629014: Recruiting study of Pediatric Intestinal Failure, sponsored by Boston Children's Hospital.
NCT04629014 is a study of Pediatric Intestinal Failure that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 750 participants. The trial reports 14 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04629014, a study of Pediatric Intestinal Failure, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada specializing in the care of these participants.
Primary Outcome
hrQOL as determined by PedsQL Generic Core at time of enrollment and corrected for time from onset of disease
Conditions Studied
Study Locations (14)
Texas
- Dallas Children's Hospital - Dallas
- UT Health Houston - Houston
Alabama
- Children's of Alabama - Birmingham
Colorado
- Children's Hospital Colorado - Aurora
Connecticut
- Connecticut Children's Medical Center - Hartford
Illinois
- Lurie Children's Hospital - Chicago
Massachusetts
- Boston Children's Hospital - Boston
Michigan
- C.S. Mott Children's Hospital - Ann Arbor
Missouri
- St. Louis Children's Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2020-02-27 |
| Est. Completion | 2029-12 |
What NCT04629014 shows while recruiting
NCT04629014 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pediatric Intestinal Failure appearing as the primary indexed condition, and to 0 interventions.
NCT04629014 lists 14 locations in 13 states (Texas, Alabama, Colorado).
Frequently Asked Questions
What is clinical trial NCT04629014 about?
NCT04629014 is a clinical study titled "Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure". This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada spe...
What is the current status of trial NCT04629014?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2020-02-27. Estimated completion is 2029-12.
What conditions does trial NCT04629014 study?
This clinical trial studies the following conditions: Pediatric Intestinal Failure.
Who is sponsoring clinical trial NCT04629014?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04629014 being conducted?
This trial has 14 study locations across Alabama, Colorado, Connecticut, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Intestinal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI